Table 2.
Missed Doses, Glycemic Measures, and Correlations in Overall, Type 1 Diabetes, and Type 2 Diabetes Evaluable Patient Population
| Parameter | Overall (n = 64) |
T1D (n = 38) |
T2D (n = 26) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Masked CGM | Unmasked CGM | P | Masked CGM | Unmasked CGM | P | Masked CGM | Unmasked CGM | P | |
| MBD per day | 0.74 ± 0.4 | 0.62 ± 0.3 | 0.008 | 0.70 ± 0.4 | 0.64 ± 0.3 | 0.237 | 0.80 ± 0.4 | 0.60 ± 0.3 | 0.010 |
| MBD per month | 22.1 ± 11.3 | 18.6 ± 9.3 | 0.008 | 20.9 ± 11.0 | 19.11 ± 9.3 | 0.237 | 23.9 ± 11.8 | 17.9 ± 9.5 | 0.010 |
| %TIR 70–180 mg/dL | 41.9 ± 18.7 | 49.0 ± 19.5 | <0.001 | 38.31 ± 18.5 | 44.46 ± 20.4 | 0.014 | 47.07 ± 18.2 | 55.63 ± 16.4 | 0.008 |
| %TAR >180 mg/dL | 53.6 ± 21.2 | 48.1 ± 20.8 | 0.004 | 55.80 ± 22.23 | 51.95 ± 22.5 | 0.161 | 50.49 ± 19.7 | 42.40 ± 16.9 | 0.010 |
| %TBR <70 mg/dL | 4.49 ± 5.0 | 2.93 ± 3.6 | <0.001 | 5.90 ± 5.70 | 3.59 ± 3.84 | <0.001 | 2.44 ± 2.9 | 1.97 ± 3.0 | 0.590 |
| HbA1c, % | 8.77 ± 1.4 | 8.37 ± 1.4 | <0.001 | 8.76 ± 1.64 | 8.38 ± 1.52 | 0.002 | 8.79 ± 1.1 | 8.36 ± 1.1 | 0.003 |
| Correlations | — | — | — | ||||||
| MBD/day with TIR | −0.241 (0.055) | −0.188 (0.138) | — | −0.387 (0.016) | −0.144 (0.389) | — | −0.044 (0.833) | −0.138 (0.502) | — |
| MBD/day with TAR | 0.229 (0.069) | 0.150 (0.238) | — | 0.392 (0.015) | 0.103 (0.539) | — | −0.068 (0.741) | 0.073 (0.723) | — |
| MBD/day with TBR | −0.030 (0.811) | 0.127 (0.317) | — | −0.188 (0.259) | 0.070 (0.674) | — | 0.442 (0.024) | 0.289 (0.152) | — |
| MBD/day with HbA1c | 0.297 (0.017) | 0.175 (0.166) | 0.317 (0.053) | 0.122 (0.467) | 0.214 (0.294) | 0.156 (0.446) | |||
Values in boldface indicate statistical significance.
CGM population, n = 64; Data are mean ± SD or r (P).
CGM, continuous glucose monitoring; MBD, missed bolus dose; r, correlation coefficient; TIR, time-in-range; TAR, time-above-range; TBR, time-below-range.